Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort

Clinical trial NCT07268664 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07268664
Sponsor: Beijing Chest Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Rifampicin Resistant Tuberculosis Pulmonary Tuberculosis Tuberculosis Drug-resistant Tuberculosis

Start date: 2025-12-01
Primary completion: 2028-05-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.